2nd Annual Clinical Data Management Innovation Europe 2025

We are pleased to announce our event 2nd Annual Clinical Data Management Innovation will be returning in 2025!

  • Brussels, Belgium
  • Ticketed
  • Why attend?
  • 2024 Agenda
  • 2024 Speakers
  • Plan Your Visit
  • 2024 Sponsors
  • Media Centre
  • Event Gallery
  • Why partner?
  • Contact Us

Why attend?

A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

The programme will feature a range of speakers from the likes of Bristol Myers Squib, Otsuka, Cerevel Therapeutics, Merck, Daiichi Sankyo and many more, who through a variety of interactive session formats will offer insight on promoting successful clinical data management.

See What It's All About

2024 Agenda

  • 6 Oct 2025
  • 7 Oct 2025
  • 8 Oct 2025
  • 9 Oct 2025
  • 10 Oct 2025
Expand All

8 AM

Registration and refreshments

8:50 AM

Chair’s opening remarks

Speakers

Hannah Hans
Director, Immunology, GlobaData

9 AM

Theory to Therapy

As the landscape of clinical research continues to evolve, the integration of Artificial Intelligence (AI) presents unprecedented opportunities for transforming clinical data management. This presentation will explore how AI is being harnessed to revolutionize solutioning and accelerate clinical trials, focusing on three main areas:

  • Master Data Management: Implementing AI tools to enhance the efficiency, accuracy, and compliance of data handling, driving significant improvements in trial outcomes.
  • Transactional Workflows: Utilizing AI to streamline and optimize clinical trial processes.
  • Agentic Workflows: Leveraging a centralized AI platform to build robust solutions that automate and improve decision-making in clinical research.

What are the practical challenges, innovative solutions, and the potential return on investment (ROI) that AI brings to clinical data management, as we move from theory to therapy.

Speakers

Jonathan Crowther
Head of Predictive Analytics , Pfizer

9:30 AM

Test-Start-Scale: The data-driven technology maturity approach

  • Test-Start-Scale - methodology that takes digital innovation on a journey from idea through refinement, all the way to wider-scale use and BAU
  • Data-driven approach which proves the value of the technology in a controlled fashion
  • Adoption of new digital capabilities with confidence and satisfaction from end user perspective

Speakers

Maja Omiecińska
Emerging Technologies Director, Global Clinical Solutions, AstraZeneca

10 AM

Revolutionising patient engagement in clinical trials: The power of Gamification

  • Are high dropout rates and patient disengagement slowing down your clinical trials and driving up costs? An introduction to gamification as a proven solution to keep patients motivated, reduce dropout rates, and improve compliance.
  • Get actionable insights on integrating gamification into your trials. Learn practical strategies to boost patient engagement while ensuring accurate data collection.
  • Explore real-world success stories. Discover how increased patient retention translated into shorter trial timelines, lower costs, and better trial outcomes.
  • See how gamification drives efficiency and savings. Understand how engaging patients more effectively can streamline your trials, reduce time to market, and significantly lower costs.

Speakers

Christer Nilsson
Chief Executive Officer, Replior

10:30 AM

Morning refreshments and networking

11:15 AM

INTERACTIVE PANEL DISCUSSION: Driving scalable innovation that will shape the future of clinical research: The latest technologies that should be on your radar

  • Assessing the value of innovation in clinical trials: sharing best practice on engaging sites with new technology
  • Training sites and staff on new systems to maximize the benefits, streamline processes and enhance patient experience
  • Selecting the right technology vendors for data collection and analysis
  • Can synthetic data succeed in overcoming data limitations?

Speakers

Maja Omiecińska
Emerging Technologies Director, Global Clinical Solutions, AstraZeneca
Nina Skorytchenko
CEO , Avenna
Hannah Hans
Director, Immunology, GlobaData
Christer Nilsson
Chief Executive Officer, Replior

12:15 PM

CDISC Conformance rules, driving the road to adoption

  • Providing an overview of the CDISC Open Rules project
  • What are CDISC Conformance rules
  • Insights about the CDISC-FDA collaboration
  • How can CDISC Open Rules help in Data Management Projects
  • What’s coming next

Speakers

Nick De Donder
CORE Product Owner , CDISC

12:45 PM

Lunch and networking

2 PM

How precision medicine technologies can be used as a complementary diagnostics to optimise clinical trial efficiency

  • Improving success rates of clinical trials for anti- inflammatory drugs using prognostic and predictive biomarkers for chronic inflammatory diseases (cIDs)
  • Overview of current and next generation biomarkers for Inflammatory Bowel Disease ( IBD)
  • GlyHealth technology– Glycomics as a Sweet Spot in Precision Medicine diagnostics
  • Addressing challenges in anti-Inflammatory drug development with GlyHealth biomarkers (stronger evidence, better selection and higher approval rates for drugs)
  • Optimising clinical trial efficiency with reliable, precision medicine biomarkers for Chronic Inflammatory Diseases (cIDs)

Speakers

Nina Skorytchenko
CEO , Avenna

2:30 PM

Navigating data consent in the digital era: innovations in clinical, healthcare, and big data technologies

  • Understanding data consent: exploring the importance and challenges of obtaining (informed) consent in the context of modern clinical and tion: examining how digital advancements and big data technologies impact data consent processes in healthcare and clinical settings, and how AI tools can enhance consent procedures for improving patient control of their data and data privacy
  • Regulatory and ethical considerations: discussing the evolving regulatory landscape and ethical considerations surrounding data consent in the era of digital health and big data, including the use of synthetic healthcare data to address privacy concerns.

Speakers

Seif Eddine Amara Madi
Senior Manager Clinical Labs Quality, GSK

3 PM

Afternoon refreshments and networking

3:45 PM

INTERACTIVE PANEL DISCUSSION: Exploring the emerging dynamic capabilities of real-world data in clinical trials to enable safer decision-making in the drug development pipeline

  • Discovering innovative, digital protocols that adapt based on real-world insights, fostering agility in study design and conduct
  • Recognising the importance of collaboration among all trial stakeholders to achieve secure access to vital RWD and maximize its true value
  • From a data management standpoint, how to ensure data traceability and integrity?
  • Promising consistency in larger data sets and compliance when handling multiple sources of data

Speakers

Brian Jingwa
Senior Manager, Team Lead, Global Data Management , Boston Scientific
Debarshi Dey
Vice President, Head of Biometrics , Galapagos
Hannah Hans
Director, Immunology, GlobaData

4:30 PM

What is the best use of blockchain for companies in relation to clinical trials?

  • New data paradigm in clinical development
  • Blockchain CRF, permission management and trend analysis
  • How stakeholders are included in the new system
  • Steps for a multichannel distribution in a health block-chain

Speakers

Dr. Jose Manuel Cervera Grau
Executive Director , Eli Lilly and Company

5 PM

Chair’s closing remarks

Speakers

Hannah Hans
Director, Immunology, GlobaData

End Of Day 1 and Networking Drinks

8 AM

Registration and refreshments

8:50 AM

Chair’s opening remarks

Speakers

Hannah Hans
Director, Immunology, GlobaData

9 AM

Interactive Speaker-Hosted Roundtable Discussions

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will be led by a table moderator and will focus on a different challenge within clinical data management. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

After 45 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

RT 1 Balancing data, patient and stakeholder priorities in clinical trial design

Hosted by Brian Jingwa, Senior Manager, Team Lead, Global Data Management, Boston Scientific

RT 2 Where does innovation fit in the highly regulated world of clinical trials?

Hosted by Nina Skorytchenko, CEO, Avenna

RT 3 Keeping up your data management strategy at the pace technology is moving at

Speakers

Brian Jingwa
Senior Manager, Team Lead, Global Data Management , Boston Scientific
Nina Skorytchenko
CEO , Avenna

10:30 AM

Morning refreshments and networking

11:15 AM

Bringing impactful data-driven leadership to all phases of drug development and successful regulatory interactions regarding new drug application

  • Discovery and preclinical phase: Target identification using big data analytics, predictive modelling for candidate selection (e.g., QSAR models) and case study for successful preclinical data-driven strategies
  • Optimizing clinical trial design: Adaptive trial designs, real-world data integration and patient recruitment and retention strategies
  • Biomarkers and precision medicine: Role in patient stratification and targeted therapies and precision medicine case study in oncology
  • Case studies and real-world examples: Success stories and lessons learned in data-driven drug development

Speakers

Debarshi Dey
Vice President, Head of Biometrics , Galapagos

11:45 AM

Vaccine development: End-to-end management of Risk-Based Quality Management (RBQM)

  • Overview of the RBQM principles
  • How can we apply those principles to Vaccine development?
  • Vaccine case study from CTQs factors to Submission

Speakers

Magali Traskine
Associate Director, Central Monitoring, GSK

12:15 PM

Lunch, networking and prize draw

1:30 PM

AI in drug discovery

  • Introduction to AI
  • Overview of AI in Drug Discovery
  • Trends Impacting AI in Drug Discovery
  • Analysis of Drugs Developed by AI

Speakers

Wafaa Hassan
Senior Strategic Intelligence Pharma Analyst, GlobalData

2 PM

INTERACTIVE PANEL DISCUSSION: Implementing risk-based strategies to streamline clinical data management for small and mid-sized biotechs

  • Collaborative approaches to optimize RBQM practices within the constraints of small and mid-sized companies
  • Employing an end-to-end risk-based data management framework into study conduct to reduce workload, burden, and timelines
  • Considering the critical factors during protocol risk assessment to reduce unnecessary protocol complexity
  • Updating monitoring frequency based on risk assessment to enhance resource allocation

Speakers

Hannah Hans
Director, Immunology, GlobaData
Dr. Jose Manuel Cervera Grau
Executive Director , Eli Lilly and Company
Magali Traskine
Associate Director, Central Monitoring, GSK

3 PM

CEO VIRTUAL SESSION Unlocking the power of integrated healthcare data: transforming patient outcomes

  • Overcoming Interoperability Challenges: Breaking Down Data Silos for Seamless Care Coordination.
  • Leveraging AI and Machine Learning to Enhance Clinical Decision Support and Predictive Analytics.
  • Implementing Robust Data Governance and Security Measures to Ensure Patient Privacy and Regulatory Compliance.
  • Harnessing Real-Time Data Analytics to Drive Personalized Care and Improve clinical outcomes.

Speakers

Chris Adams
CEO, Andarix Pharmaceuticals

3:30 PM

Chair’s closing remarks

Speakers

Hannah Hans
Director, Immunology, GlobaData

END OF CONFERENCE

2024 Speakers

Select a speaker to learn more

Back
Jonathan Crowther
Head of Predictive Analytics , Pfizer

With a keen eye for Strategic Vision, Jonathan has been at the forefront of advancing analytical capabilities, particularly in site intelligence, operational metrics, and quality indicators. With a prowess in Digital Transformation has been instrumental in the on-time delivery and precision of a diverse suite of predictive models, leveraging ML/AI and Generative AI technologies.

Session Details:

Theory to Therapy

2024-11-19, 9:00 AM

View In Agenda
Next speaker
Back
Maja Omiecińska
Emerging Technologies Director, Global Clinical Solutions, AstraZeneca

Digital innovation business leader with vision for turning bold technology innovations into operational realities.

As Emerging Technologies Director I am accountable for the collaboration with cross functional business partners in managing the delivery of promoting solutions between test/start/scale. I am accountable for understanding the demands and implications of solutions and will ensure that the organisation has the capability and capacity to achieve business outcomes with agreement and clarity around roles and responsibility. My role is to forge relationships with internal and external partners to build best practice and establish new ways of working.

My mission is to introduce innovative technologies in AstraZeneca clinical trials, paving the way towards operational excellence.

Session Details:

Test-Start-Scale: The data-driven technology maturity approach

2024-11-19, 9:30 AM

Session Details:

INTERACTIVE PANEL DISCUSSION: Driving scalable innovation that will shape the future of clinical research: The latest technologies that should be on your radar

2024-11-19, 11:15 AM

View In Agenda
Next speaker
Back
Dr. Jose Manuel Cervera Grau
Executive Director , Eli Lilly and Company

Joined to the project of biotechnologies in 2012, at the beginning of the Advanced Therapies. The labour as Oncologist in Big Pharma from September of 2016 until today has been taking part of international research organizations in which participated actively; Working as a Cross-functional role for Spain and Portugal, clinical development of Lilly portfolio, deep dive of clinical trials and preclinical studies of new drugs, from First Human dose to Phase III/IV. Expert in Regulatory terms and access negotiation, in Pre-launching and Clinical Launching of drugs developing the brand plan and operational plans supporting all implicated areas, from I+D, clinical operations, to marketing and sales.

Other Qualities are management and leadership, strategy and innovation, technology, operations, and value chain management, Emotional intelligence and empathy. The road map to achieve all theses capabilities has been intense working in 10 Hospitals, in basic science, preclinical research in Advanced Therapy Medicinal Product, developing drugs from human origen from Wharthon´s jelly MSCs, fat and dental pulp to recover damaged soft tissue, chronic stroke and chemotherapy damage and been author of books papers, communications in international meetings and participating in many advanced projects nationwide health demonstrating great capacity for teamwork to solve complex situations.

Session Details:

What is the best use of blockchain for companies in relation to clinical trials?

2024-11-19, 4:30 PM

Session Details:

INTERACTIVE PANEL DISCUSSION: Implementing risk-based strategies to streamline clinical data management for small and mid-sized biotechs

2024-11-20, 2:00 PM

View In Agenda
Next speaker
Back
Nick De Donder
CORE Product Owner , CDISC

Biography

Nick De Donder graduated as a biomedical scientist from the University of Ghent, Belgium in 2007 and has been employed since 2008 by Business & Decision Life Sciences at their headquarters in Brussels. He has been moving from being a Data Integration Specialist to Project Manager to Line Manager for the Data Standards team. Since 2020 he is Head of Data Standards. Nick is a member of the SDS team, an authorized CDISC trainer for CDASH, SDTM and Newcomers and a PHUSE committee member since 2017. In 2019 he joined the E3C and is now co-chairing it. Since June 2021 Nick has been product owner of the CORE application.

Session Details:

CDISC Conformance rules, driving the road to adoption

2024-11-19, 12:15 PM

View In Agenda
Next speaker
Back
Debarshi Dey
Vice President, Head of Biometrics , Galapagos

Debarshi is currently Global Head of Biostatistics and Data Management consisting of approximately 30 Biostatisticians, Statistical Programmers and Data Managers across two global sites in Munich, Germany and Boston, USA for a Bio-Pharmaceutical company engaged in bringing novel drugs in Oncology and Auto-immune disease to patients.

With more than 11 years of experience in drug development in the pharmaceutical industry, Debarshi has extensive and proven track-record of impactful data-driven leadership in all phases of drug development and successful regulatory interactions regarding New Drug Application (NDA) and Biologics License Application (BLA) with USFDA, EMA, and PMDA.

Debarshi was the Lead Statistician of a pivotal oncology study with a real-world component, which resulted in a successful FDA approval in July 2020. In the course of the path to approval, Debarshi provided strategic leadership, led multiple interactions with FDA and provided strong statistical input in regulatory aspects of the submission. Debarshi has designed Phase I-III clinical trials, with complex adaptive features, calculating optimal sample size taking advantage of advanced simulation methods.

In his current role, Debarshi has been instrumental in setting up a fully functional Statistics and Data Management Department from scratch , including a CFR 21 Part 11 validated SAS programming environment for performing in-house programming.

Session Details:

INTERACTIVE PANEL DISCUSSION: Exploring the emerging dynamic capabilities of real-world data in clinical trials to enable safer decision-making in the drug development pipeline

2024-11-19, 3:45 PM

Session Details:

Bringing impactful data-driven leadership to all phases of drug development and successful regulatory interactions regarding new drug application

2024-11-20, 11:15 AM

View In Agenda
Next speaker
Back
Magali Traskine
Associate Director, Central Monitoring, GSK

Magali specialises in:

- Risk Based Quality Monitoring
- Centralized Monitoring
- Processes improvement
- Statistical optimizations
- Feasibility
- Vaccines
- Mentoring
- Coaching
- People management

Session Details:

Vaccine development: End-to-end management of Risk-Based Quality Management (RBQM)

2024-11-20, 11:45 AM

Session Details:

INTERACTIVE PANEL DISCUSSION: Implementing risk-based strategies to streamline clinical data management for small and mid-sized biotechs

2024-11-20, 2:00 PM

View In Agenda
Next speaker
Back
Cristina De Juan
Global Clinical Sciences and Operations Innovation Lead , UCB

Digital innovation business leader experienced in setting and scaling up digital solutions in the
pharmaceutical space. My mission is to foster innovation in digital health, with the aim to advance healthcare and help patients.

Next speaker
Back
Nina Skorytchenko
CEO , Avenna

Nina is the co-founder and CEO of Avenna Ltd. Her mission is to make healthcare for chronic inflammatory disease (CIDs) more preventive and personalised. By developing more effective, affordable, and accessible precision medicine solutions we can enable early detection and treatment personalisation for variety of CIDs. Nina has background in finance, business, and healthcare and worked in large multinational companies including Nomura, Bloomberg and Schlumberger, as well as several entrepreneurship ventures.

Nina’s main ability and expertise is to connect the worlds of scientific research and business. She uses this experience to translate the most promising, research-grade technologies into practical solutions for individuals, clinicians, and biopharma. Nina works in collaboration with leading scientists, clinicians, and patients to translate R&D stage technologies into practical clinical solutions. This includes design and execution of clinical studies and trials, development of bioinformatics infrastructure to facilitate the translation of precision health programs for chronic disease prevention into clinical practice.

Session Details:

Interactive Speaker-Hosted Roundtable Discussions

2024-11-20, 9:00 AM

Session Details:

INTERACTIVE PANEL DISCUSSION: Driving scalable innovation that will shape the future of clinical research: The latest technologies that should be on your radar

2024-11-19, 11:15 AM

Session Details:

How precision medicine technologies can be used as a complementary diagnostics to optimise clinical trial efficiency

2024-11-19, 2:00 PM

View In Agenda
Next speaker
Back
Brian Jingwa
Senior Manager, Team Lead, Global Data Management , Boston Scientific

Session Details:

Interactive Speaker-Hosted Roundtable Discussions

2024-11-20, 9:00 AM

Session Details:

INTERACTIVE PANEL DISCUSSION: Exploring the emerging dynamic capabilities of real-world data in clinical trials to enable safer decision-making in the drug development pipeline

2024-11-19, 3:45 PM

View In Agenda
Next speaker
Back
Wafaa Hassan
Senior Strategic Intelligence Pharma Analyst, GlobalData

Wafaa Hassan, MSc, is a Senior Pharma Analyst in the Digital team at GlobalData’s London office. Her responsibilities involve writing reports and providing insights on digital strategy across disease areas and channels. Prior to working in the digital team, Wafaa worked in the thematic research team at GlobalData, where she contributed to quantitative and qualitative analysis reports on disruptive themes and technologies, with a focus on Pharma, Healthcare and Medical Devices sectors. Prior to joining GlobalData, Wafaa studied for an MSc in Healthcare Management at City, University of London.

Session Details:

AI in drug discovery

2024-11-20, 1:30 PM

View In Agenda
Next speaker
Back
Christer Nilsson
Chief Executive Officer, Replior

Christer Nilsson is a dynamic entrepreneur and the CEO of Replior, bringing over 30 years of leadership experience in IT, Finance, and Life Sciences. Throughout his career, he has successfully launched and managed several businesses with a strong focus on innovation and customer satisfaction. At Replior, Mr. Nilsson is committed to a transparent and honest approach, ensuring that clients' needs are at the heart of every decision. He leads the integration of cutting-edge digital endpoints, sensor technology, and gamification strategies into clinical research solutions, aimed at reducing patient dropout and increasing compliance. Under his leadership, Replior is pioneering a more patient-centric and effective model for clinical trials.

Session Details:

Revolutionising patient engagement in clinical trials: The power of Gamification

2024-11-19, 10:00 AM

Session Details:

INTERACTIVE PANEL DISCUSSION: Driving scalable innovation that will shape the future of clinical research: The latest technologies that should be on your radar

2024-11-19, 11:15 AM

View In Agenda
Next speaker
Back
Seif Eddine Amara Madi
Senior Manager Clinical Labs Quality, GSK

Session Details:

Navigating data consent in the digital era: innovations in clinical, healthcare, and big data technologies

2024-11-19, 2:30 PM

View In Agenda
Next speaker
Back
Chris Adams
CEO, Andarix Pharmaceuticals

Mr. Adams has been a founder or co-founder of life science and technology based companies in Massachusetts for the past several years. Mr. Adams has been instrumental in developing new proprietary therapeutic and medical device technologies and bringing the technologies to commercialization. The companies he has founded include, Compellis Pharmaceuticals, a developer of therapeutics to treat obesity and its co-morbidities, diabetes and hypertension and Mosaic Technologies, a venture backed MIT spin-out genomics company that developed patented technologies for genetic analysis and detection. Chris is the holder of more than 20 issued US and international patents for medical devices and pharmaceuticals.

Session Details:

CEO VIRTUAL SESSION Unlocking the power of integrated healthcare data: transforming patient outcomes

2024-11-20, 3:00 PM

View In Agenda
Next speaker
Back
Hannah Hans
Director, Immunology, GlobaData

Hannah Zara Hans, MPharm, PG Clin Dip, EMBA, is the Director for Immunology at GlobalData, London. Hannah has over 13 years of experience in pharma and the clinical setting. She has experience in medical and commercial strategy across a breadth of therapy areas for products at various stages of development. Before Joining GlobalData, Hannah spent nine years at GSK working across therapy areas including Respiratory, HIV, and Early Assets. Her pharma experience included working on launch, competitor, and external engagement strategies for Respiratory and Infectious Diseases. Most recently, Hannah completed a secondment within the commercial Early Asset Portfolio Strategy team at GSK. Additionally, Hannah worked as a Clinical Pharmacist for four years within the hospital setting and a Clinical Commissioning Group in Manchester. Hannah holds a Master of Pharmacy from the University of Kent, a Post-Graduate Clinical Diploma from the University of Bradford, and an Executive Master of Business Administration (EMBA) from London Business School.

Session Details:

Chair’s opening remarks

2024-11-20, 8:50 AM

Session Details:

Chair’s opening remarks

2024-11-19, 8:50 AM

Session Details:

INTERACTIVE PANEL DISCUSSION: Driving scalable innovation that will shape the future of clinical research: The latest technologies that should be on your radar

2024-11-19, 11:15 AM

Session Details:

INTERACTIVE PANEL DISCUSSION: Exploring the emerging dynamic capabilities of real-world data in clinical trials to enable safer decision-making in the drug development pipeline

2024-11-19, 3:45 PM

Session Details:

Chair’s closing remarks

2024-11-19, 5:00 PM

Session Details:

INTERACTIVE PANEL DISCUSSION: Implementing risk-based strategies to streamline clinical data management for small and mid-sized biotechs

2024-11-20, 2:00 PM

Session Details:

Chair’s closing remarks

2024-11-20, 3:30 PM

View In Agenda
Next speaker

Plan Your Visit

Venue

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

2024 Sponsors

Select a sponsor to learn more

Session Sponsors

Exhibitors

Why partner?

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 100+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

Become A Media Partner

 A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

The programme will feature a range of speakers from the likes of Bristol Myers Squib, Otsuka, Cerevel Therapeutics, Merck, Daiichi Sankyo and many more, who through a variety of interactive session formats will offer insight on promoting successful clinical data management.

See What It's All About

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Conor Taylor

Sponsorship Sales Manager

+44 (0) 20 7936 6870

SPEAKER ENQUIRIES

Ralitsa Pashkuleva

Conference Producer

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact

Conor Taylor

Sponsorship Sales Manager


+44 (0) 20 7936 6870

SPEAKER ENQUIRES

To enquire about speaking opportunities for the conference, please contact:

Ralitsa Pashkuleva

Conference Producer